Business Development Clinical Development Genetic Disease Life Science 
The Pharma Data
DECEMBER 8, 2020
December is bringing frost in the North and plenty of cold hard cash for these life sciences companies. . European venture capital firm Forbion rounded up $545 million for its fifth life sciences fund. The impact of CNS diseases extends beyond patients—to their families and society as well.”
The Pharma Data
OCTOBER 15, 2020
The committee is tasked with supporting BeyondSpring’s business development activities related to its lead asset, Plinabulin, and other pipeline assets. Mukul Agarwal, former vice president of Corporate Development, at Forty Seven, Inc., Prior to joining Genalyte, Hanna served as COO at Verily Life Sciences.
Expert insights. Personalized for you.
52 
Let's personalize your content